April 30, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Obviousness-type double patenting in the Age of the Twenty-Year Term and Patent Term Adjustment |
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Obviousness-type double patenting in the Age of the Twenty-Year Term and Patent Term Adjustment |
Biotechnology

Obviousness-type double patenting in the Age of the Twenty-Year Term and Patent Term Adjustment |

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


Obviousness-type double patenting (ODP) attempts to prevent the term of a “reference patent” claiming an obvious variant of a parent patent to exceed the term of the parent. This fulfills the mandate of the patent statute of “one patent per invention.”

When issuance dates were compared pre URAA (1994), the need to file for terminal disclaimer (TD) in the later-issued patent was simple to resolve. But then came patent term adjustment (PTA) – time tacked onto an expiration date for PTO delay—and URAA (1994)’s twenty years from filing or priority date term –arrived to complicate determination of if and when ODP is an…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Treatments to help utilities prepare for PFAS water regulations 

Environmental Science
June 20, 2025

Guide To PUPSIT And Annex 1 In Aseptic Processing

Source: Cytiva Aseptic processing is critical to ensuring drug safety, and evolving global regulations are…

April 30, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Genesis Mission and New Guidance for AI-Assisted Inventions  

The Federal government is accelerating AI‑enabled innovation by launching the Genesis Mission, a sweeping national initiative to accelerate scientific discovery…

Biotechnology
December 7, 2025

AI, Algorithms and Abstract Ideas: Federal Circuit Reinforces Limits in Recentive v. Fox

In April, the Federal Circuit issued a significant patent law ruling involving artificial intelligence. In Recentive Analytics, Inc. v. Fox…

Biotechnology
June 27, 2025

The Crucial Role of Patent Due Diligence in Mergers & Acquisitions: Spotting Patent Litigation Risks Before Closing a Deal

In today’s rapidly evolving business landscape, mergers and acquisitions (“M&A”) remain a common strategic priority for companies aiming to grow,…

Biotechnology
April 5, 2025

Eye Therapies v. Slayback Pharma – Fed. Cir. Enhances the Scope of “Consisting Essentially” |

In Eye Therapeutics, LLC, v. Slayback Pharma, LLC., Appeal no. 2023-2173, (Fed. Cir., June 30, 2025), a panel of Judges…

Biotechnology
July 18, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Guide To PUPSIT And Annex 1 In Aseptic Processing
April 30, 2026
Detecting Neurodegenerative Disease Markers
April 30, 2026
Advanced Wound Care OTC Market Technology Adoption and Forecast
April 29, 2026
Healthcare RPO Market Demand Rising Across Pharma and Hospitals
April 29, 2026

Life Science Magazines

Guide To PUPSIT And Annex 1 In Aseptic Processing
April 30, 2026
Detecting Neurodegenerative Disease Markers
April 30, 2026
Sample Quality Control In Next-Generation Sequencing…
April 29, 2026
Correlating NGS Success With Sample Input Quality: A Large…
April 29, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?